Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways.
Journal of the American College of Cardiology
oregon; cards; cards publication; covid-19; Arrhythmias, Cardiac; COVID-19; Critical Pathways; Extracorporeal Membrane Oxygenation; Female; Humans; Middle Aged; Myocarditis; SARS-CoV-2
A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter-defibrillator and antiarrhythmic drug therapy.
Rajpal, Saurabh; Kahwash, Rami; Tong, Matthew S; Paschke, Kelly; Satoskar, Anjali A; Foreman, Beth; Allen, Larry A; Bhave, Nicole M; Gluckman, Tyler J; and Fuster, Valentin, "Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways." (2022). Articles, Abstracts, and Reports. 6288.